Apatinib sensitizes chemoresistant NSCLC cells to doxetaxel via regulating autophagy and enhances the therapeutic efficacy in advanced and refractory/recurrent NSCLC

The prognosis of advanced non-small cell lung cancer (NSCLC) is poor; therefore, identifying novel treatment strategies for patients with NSCLC is important. The present study aimed to investigate the efficacy of apatinib plus docetaxel vs. docetaxel alone, as well as their effects on regulating aut...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Med Rep
Autori principali: Hu, Rong, Li, Tao, Hui, Kaiyuan, Chen, Zi, Wang, Nan, Wu, Xingping, Ge, Linyang, Zhou, Linfu
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2020
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7533512/
https://ncbi.nlm.nih.gov/pubmed/32901884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2020.11492
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi